News

News

Canadian Employers Will Face a $5.6 Billion Price Tag for Specialty Drugs Within the Next Five Years

Tuesday, May 10, 2016

Le Lezard (EN) - Express Scripts Canada, one of the country's leading providers of health benefits management services, today announced the results of its annual Drug Trend Report. 

Germany To Legalize Medical Marijuana Next Year

Sunday, May 8, 2016

IFL Science - Germany is set to become the latest country to legalize the use of cannabis for medicinal purposes, with the nation’s health minister confirming earlier this week that the German cabinet had approved the move. 

Valeant Pharmaceuticals announces shakeup on its board of directors

Friday, May 6, 2016

Valeant Pharmaceuticals is shaking up its board of directors, with half of them not standing for re-election, the Quebec-based drugmaker announced Friday. 

Concordia Healthcare: Diving deep into claims of sky high prices

Friday, May 6, 2016

BNN - Business News Network - Anyone with a passing interest in healthcare knows the practice of drug price increases has come under scrutiny lately. Concerns around this scrutiny evolving into new regulations or legal troubles have wiped out stock values in the process. 

Valeant is going to review how it sets prices for drugs (May 06, 2016 )

Friday, May 6, 2016

CTV Montreal News - Embattled drug manufacturer Valeant Pharmaceuticals International (TSX:VRX) is revamping the way it prices drugs.
The company issued a statement late Thursday saying it is forming a new "patient access and pricing committee" that will be responsible for what it charges for prescription drugs. 

FDA takes significant steps to protect Americans from dangers of tobacco through new regulation

Thursday, May 5, 2016

Le Lezard (EN) - The U.S. Food and Drug Administration finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco and pipe tobacco, among others.  

Warren Buffett calls Valeant strategy 'flawed'

Monday, May 2, 2016

Toronto - CBC News - Investor Warren Buffett said Berkshire Hathaway has called the business model of Valeant Pharmaceuticals flawed and panned the company's leadership. 

Cipher Pharmaceuticals Acquires Worldwide Rights to Dalhousie University's Investigational Tattoo Removal Cream

Monday, May 2, 2016

 Le Lezard (EN)Cipher Pharmaceuticals Acquires Worldwide Rights to Dalhousie University's Investigational Tattoo Removal Cream 

Displaying results 51-59 (of 59)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 >  >|

Member Forum

September 17, 2019
Angus Glen Golf Club
Markham, Ontario

MORE INFO

2018 CAPDM Boot Camp Series

November 7 - 8, 2018
Sheraton Toronto Airport Hotel & Conference Centre
Toronto, Ontario

MORE INFO

Executive Conference

January 14 - 15, 2019
Montreal Airport Marriott In-Terminal Hotel
Dorval, QC

MORE INFO

Annual Conference

May 5 - 8, 2019
Park Hyatt Aviara Resort
Carlsbad, CA

MORE INFO